External Control Arms and Data Analysis Methods in Nonrandomized Trial of Patients With Glioblastoma.
作者信息
Rahman Rifaquat, Ventz Steffen, Trippa Lorenzo
机构信息
Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts.
Division of Biostatistics, University of Minnesota, Minneapolis.
出版信息
JAMA Oncol. 2023 Jul 1;9(7):1006-1007. doi: 10.1001/jamaoncol.2023.1069.
Abstract
摘要
相似文献
1
External Control Arms and Data Analysis Methods in Nonrandomized Trial of Patients With Glioblastoma.
JAMA Oncol. 2023 Jul 1;9(7):1006-1007. doi: 10.1001/jamaoncol.2023.1069.
2
External Control Arms and Data Analysis Methods in Nonrandomized Trial of Patients With Glioblastoma.
JAMA Oncol. 2023 Jul 1;9(7):1006. doi: 10.1001/jamaoncol.2023.1066.
3
External Control Arms and Data Analysis Methods in Nonrandomized Trial of Patients With Glioblastoma-Reply.
JAMA Oncol. 2023 Jul 1;9(7):1007-1008. doi: 10.1001/jamaoncol.2023.1072.
4
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial.
JAMA Oncol. 2023 Jan 1;9(1):112-121. doi: 10.1001/jamaoncol.2022.5370.
5
Current therapies for glioblastoma.
Clin Adv Hematol Oncol. 2004 Sep;2(9):572-3.
6
Treatment of newly diagnosed glioblastoma in the elderly: a network meta-analysis.
Cochrane Database Syst Rev. 2020 Mar 23;3(3):CD013261. doi: 10.1002/14651858.CD013261.pub2.
7
Biomarker-based adaptive trials for patients with glioblastoma--lessons from I-SPY 2.
Neuro Oncol. 2013 Aug;15(8):972-8. doi: 10.1093/neuonc/not088. Epub 2013 Jul 14.
8
Leveraging external data in the design and analysis of clinical trials in neuro-oncology.
Lancet Oncol. 2021 Oct;22(10):e456-e465. doi: 10.1016/S1470-2045(21)00488-5.
9
Highlighting the need for reliable clinical trials in glioblastoma.
Expert Rev Anticancer Ther. 2018 Oct;18(10):1031-1040. doi: 10.1080/14737140.2018.1496824. Epub 2018 Jul 12.
10
Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with simultaneous integrated boost guided by MR spectroscopic imaging.
BMC Cancer. 2019 Feb 21;19(1):167. doi: 10.1186/s12885-019-5317-x.
引用本文的文献
1
Immunotherapeutic Strategies for the Treatment of Glioblastoma: Current Challenges and Future Perspectives.
Cancers (Basel). 2024 Mar 25;16(7):1276. doi: 10.3390/cancers16071276.
2
Leveraging external control data in the design and analysis of neuro-oncology trials: Pearls and perils.
Neuro Oncol. 2024 May 3;26(5):796-810. doi: 10.1093/neuonc/noae005.
本文引用的文献
1
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial.
JAMA Oncol. 2023 Jan 1;9(1):112-121. doi: 10.1001/jamaoncol.2022.5370.
2
Leveraging external data in the design and analysis of clinical trials in neuro-oncology.
Lancet Oncol. 2021 Oct;22(10):e456-e465. doi: 10.1016/S1470-2045(21)00488-5.
3
Design and Evaluation of an External Control Arm Using Prior Clinical Trials and Real-World Data.
Clin Cancer Res. 2019 Aug 15;25(16):4993-5001. doi: 10.1158/1078-0432.CCR-19-0820. Epub 2019 Jun 7.
4
Matching-adjusted indirect comparisons: a new tool for timely comparative effectiveness research.
Value Health. 2012 Sep-Oct;15(6):940-7. doi: 10.1016/j.jval.2012.05.004.
5
A definition of causal effect for epidemiological research.
J Epidemiol Community Health. 2004 Apr;58(4):265-71. doi: 10.1136/jech.2002.006361.
Zotero 插件